Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recognizing the fetus at risk

C J Dewhurst

    Postgraduate Medicine
    |June 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Fetal growth retardation can stem from poor fetal growth potential or placental support issues. Congenital abnormalities are linked to impaired growth potential, necessitating investigations like amniocentesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Ornstein-Uhlenbeck third-order Gaussian process (OUGP) applied directly to the un-resampled heart rate variability (HRV) tachogram for detrending and low-pass filtering.

    Medical & biological engineering & computing·2012
    Same author

    An efficient time-varying filter for detrending and bandwidth limiting the heart rate variability tachogram without resampling: MATLAB open-source code and Internet web-based implementation.

    Computational and mathematical methods in medicine·2012
    Same author

    Amenorrhœa and galactorrhœa.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Spironolactone in the treatment of hirsutism.

    Acta obstetricia et gynecologica Scandinavica·1986
    Same author

    Human amnion in the treatment of vaginal malformations.

    British journal of obstetrics and gynaecology·1986
    Same author

    Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.

    British journal of obstetrics and gynaecology·1985
    Same journal

    Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

    Postgraduate medicine·2026
    Same journal

    Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

    Postgraduate medicine·2026
    Same journal

    The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

    Postgraduate medicine·2026
    Same journal

    Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

    Postgraduate medicine·2026
    Same journal

    Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

    Postgraduate medicine·2026
    Same journal

    Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

    Postgraduate medicine·2026
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Fetal Medicine
    • Reproductive Health

    Background:

    • Fetal growth retardation (FGR) arises from diminished fetal growth potential or inadequate placental support.
    • Impaired fetal growth potential often correlates with congenital abnormalities.
    • Risk factors for fetal anomalies are identified through patient history, including reproductive and family history.

    Purpose of the Study:

    • To outline the causes and diagnostic approaches for fetal growth retardation.
    • To differentiate between impaired fetal growth potential and poor placental support.
    • To guide obstetric management based on the etiology of FGR.

    Main Methods:

    • Review of clinical findings and patient history to assess risk factors.
    • Diagnostic investigations including amniocentesis, ultrasound for fetal growth monitoring, and radiologic studies.

    Related Experiment Videos

  • Evaluation of maternal medical history, specifically hypertension and toxemic disorders.

    • Main Results:

    • Congenital abnormalities are associated with impaired fetal growth potential.
    • Patient history is crucial for identifying increased risk of fetal anomalies.
    • Poor placental growth support is a more frequent cause of FGR than impaired growth potential.

    Conclusions:

    • Fetal growth retardation necessitates a thorough evaluation of both fetal and placental factors.
    • Diagnostic interventions are indicated when fetal anomaly risk is elevated.
    • Maternal conditions like hypertension warrant vigilant fetal monitoring for suspected placental insufficiency.